Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK vaccines minister says Pfizer supply tight but on track for target

Fri, 11th Jun 2021 11:45

(Alliance News) - UK vaccines minister Nadhim Zahawi has admitted that Pfizer Inc-BioNTech SE vaccine supplies will be "tight" over the next few weeks, but said he is still confident of offering every adult a first dose by the end of July.

It comes after Scotland's Health Secretary warned supply of the vaccine will be "particularly tight" over the next few weeks, restricting the vaccination programme's rollout.

Humza Yousaf has written to his UK government counterpart Matt Hancock to ask what can be done to increase the supply of the vaccine.

But Zahawi told LBC: "I am absolutely confident, and I'll speak to Humza on this, that we will be able to deliver the Pfizer vaccines that Scotland needs to be able to meet its targets for end of July, as the UK target."

Asked if it would be "tight" in the next few weeks, he said: "It will be, there is no doubt. Every time I've come on your show I've said that the determining factor in terms of vaccine-in-arms is supply.

"And supply remains finite, but it is stable, and Pfizer have done a great job in being consistent on their delivery schedule.

"Pfizer have done remarkable things to increase their production, not just for us but for the whole world, for Europe and the US as well. But it is tight."

He said every country has a delivery schedule, adding: "I'm confident that Scotland will be able to meet the target of offering every adult at least one dose by the end of July, as we will in England as well."

Pfizer said in a statement: "We are working relentlessly to support the rollout of Covid-19 vaccination campaigns worldwide.

"In the UK, quarter one deliveries, January to March, were completed in line with our contractual agreement and we remain on course to continue to deliver a steady supply of vaccines to the UK, in accordance with the monthly schedule, agreed in advance with the Vaccines Taskforce.

"Decisions on dosing regimens and how best to roll out the vaccination programme to priority groups sit with the health authorities in each country."

Ahead of a four-nation call on Thursday, Yousaf said Scotland needs more Pfizer-BioNTech doses if it is to "maintain or increase" the rollout.

He said he was "conscious" that a recommendation from the Joint Committee on Vaccination & Immunisation that the AstraZeneca PLC vaccine should not be used for those under 40 had placed "increased pressure" on supplies.

By Emma Bowden, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.